Regulation (EC) No 1901/2006, as amended by Regulation (EC) No 1902/2006, provides that the Commission may impose financial penalties for infringement of its provisions or the implementing measures adopted pursuant to it in relation to medicinal products authorised through the procedure laid down in Regulation (EC) No 726/2004. It also empowers the Commission to adopt measures concerning the maximum amounts of those penalties and the conditions and methods for their collection. Since Regulation (EC) No 658/2007 concerns financial penalties for infringement of certain obligations in connection with marketing authorisations granted under Regulation (EC) No 726/2004, it is appropriate, for reasons of consistency, to include in the scope of Regulation (EC) No 658/2007 the obligations provided for in Regulation (EC) No 1901/2006 whose infringement may give rise to financial penalties under that same Regulation.
Recital 2, Commission Regulation (EU) No 488/2012 of 8 June 2012 amending Regulation (EC) No 658/20…
In forcesince 8 Jun 2012
Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…Law
Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 Decembe…Law
Regulation (EC) No 1902/2006 of the European Parliament and of the Council of 20 Decembe…Law
Commission Regulation (EC) No 658/2007 of 14 June 2007 concerning financial penalties fo…Law